Analysis of medicinal and therapeutic potential of Withania somnifera derivatives against COVID-19

References

• Adedeji, A. O., Marchand, B., Te Velthuis, A. J. W., Snijder, E. J., Weiss, S., Eoff, R. L., Singh, K., & Sarafianos, S. G. (2012). Mechanism of nucleic acid unwinding by SARS-CoV helicase. PLoS One, 7(5), e36521. https://doi.org/10.1371/journal.pone.0036521.
   PubMed Web of Science ®Google Scholar
• Ahn, D. G., Choi, J. K., Taylor, D. R., & Oh, J. W. (2012). Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Archives of Virology, 157(11), 2095–2104. https://doi.org/10.1007/s00705-012-1404-x.
   PubMed Web of Science ®Google Scholar
• Aronson, J. K. (2020). Coronaviruses – A general introduction. Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford.
   Google Scholar
• Baez-Santos, Y. M., St John, S. E., & Mesecar, A. D. (2015). The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Research, 115, 21–38. https://doi.org/10.1016/j.antiviral.2014.12.015.
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bhardwaj, K., Palaninathan, S., Alcantara, J. M. O., Yi, L. L., Guarino, L., Sacchettini, J. C., & Kao, C. C. (2008). Structural and functional analyses of the severe acute respiratory syndrome coronavirus endoribonuclease Nsp15. The Journal of Biological Chemistry, 283(6), 3655–3664. https://doi.org/10.1074/jbc.M708375200.
   PubMed Web of Science ®Google Scholar
• Bonanno, J. B., Fowler, R., Gupta, S., Hendle, J., Lorimer, D., Romero, R., Sauder, J. M., Wei, C. L., Liu, E. T., Burley, S. K., & Harris, T. (2003). X-ray crystal structure of the SARS coronavirus main protease. Rcsb Pdb. doi. https://doi.org/10.2210/pdb1q2w/pdb
   Google Scholar
• Cai, Z., Zhang, G., Tang, B., Liu, Y., Fu, X., & Zhang, X. (2015). Promising anti-influenza properties of active constituent of Withania somnifera ayurvedic herb in targeting neuraminidase of H1N1 influenza: computational study. Cell Biochemistry and Biophysics, 72(3), 727–739. https://doi.org/10.1007/s12013-015-0524-9.
   PubMed Web of Science ®Google Scholar
• Chan, J. F., Yuan, S., Kok, K. H., To, K. K. W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C. Y., Poon, R. W. S., Tsoi, H. W., Lo, S. K. F., Chan, K. H., Poon, V. K. M., Chan, W. M., Ip, J. D., Cai, J. P., Cheng, V. C. C., Chen, H., Hui, C. K. M., & Yuen, K. Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet, 395(10223), 514–523. https://doi.org/10.1016/S0140-6736(20)30154-9
   PubMed Web of Science ®Google Scholar
• Deng, X., & Baker, S. C. (2018). An “Old” protein with a new story: Coronavirus endoribonuclease is important for evading host antiviral defenses. Virology, 517, 157–163. https://doi.org/10.1016/j.virol.2017.12.024
   PubMed Web of Science ®Google Scholar
• Dhawan, M., , D., Parmar, M., , Sharun, k., ., Tiwari, R., , Bilal, M., & Dhama. K.(2021). Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19. Journal of Applied Pharmaceutical Science, 11, 006–013. https://doi.org/10.7324/JAPS.2021.110402
   Google Scholar
• Doublie, S., & Ellenberger, T. (1998). The mechanism of action of T7 DNA polymerase. Current Opinion in Structural Biology, 8(6), 704–712. https://doi.org/10.1016/S0959-440X(98)80089-4
   PubMed Web of Science ®Google Scholar
• Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B. J., & Jiang, S. (2009). The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nature Reviews. Microbiology, 7(3), 226–236. https://doi.org/10.1038/nrmicro2090.
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477. https://doi.org/10.1016/j.lfs.2020.117477.
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Cari-Cato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Vereven, T., Montgomery, J. A., Peralta, J. E., Ogliaro, F., Bearpark, M.,Heyd, J. J., Brothers, E., Kudin, K. N., Staroverov, V. N., Kobayashi, R., Normand, J., Raghavachari, K., Rendell, A., Burant, J. C., Iyengar, S. S., Tomasi, J., Cossi, M., Rega, N., Millam, J. M., Klene, M., Knox, J. E., Cross, J. B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R. E., Yazyev, o., Austin, A. J., Cammi, R., Pomelli, C., Ochterski, J. W., Martin, R. L., Morokuma, K., Zakrzewski, V. G., Voth, G. A., Salvador, P., Dannenberg, J. J., Dapprich, S., Daniels, A. D., Farkas, O., Foresman, J. B., Ortiz, J. V., Cioslowski, J., Fox, D. J. (2009). Gaussian, Inc. Gaussian 09, revision A.02. Gaussian, Inc.
   Google Scholar
• Ghosh, A. K., Takayama, J., Rao, K. V., Ratia, K., Chaudhuri, R., Mulhearn, D. C., Lee, H., Nichols, D. B., Baliji, S., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2010). Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: Design, synthesis, protein-ligand X-ray structure and biological evaluation. Journal of Medicinal Chemistry, 53(13), 4968–4979. https://doi.org/10.1021/jm1004489.
   PubMed Web of Science ®Google Scholar
• Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., Niemeyer, D., Schneider, H., Drosten, C., & Pöhlmann, S. (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology, 85(9), 4122–4134. https://doi.org/10.1128/jvi.02232-10.
   PubMed Web of Science ®Google Scholar
• Han, D. P., Lohani, M., & Cho, M. W. (2007). Specific asparagine-linked glycosylation sites are critical for DC-SIGN-and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. Journal of Virology, 81(21), 12029–12039. https://doi.org/10.1128/JVI.00315-07
   PubMed Web of Science ®Google Scholar
• Hilgenfeld, R. (2014). From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. The FEBS Journal, 281(18), 4085–4096. https://doi.org/10.1128/JVI.00315-07.
   PubMed Web of Science ®Google Scholar
• Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., Pallansch, M. A., Weldon, W. C., Biggs, H. M., Uyeki, T. M., Pillai, S. K. (2020). First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/NEJMoa2001191.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5.
   PubMedGoogle Scholar
• Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019). TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J. Virol, 93, e01815–18. https://doi.org/10.1128/JVI.01815-18
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Kahn, J. S., & McIntosh, K. (2005). History and recent advances in coronavirus discovery. The Pediatric Infectious Disease Journal, 24(11 Suppl), S223–S227. https://doi.org/10.1097/01.inf.0000188166.17324.60.
   PubMedGoogle Scholar
• Kalra, R. S., Kumar, V., Dhanjal, J. K., Garg, S., Li, X., Kaul, S. C., Sundar, D., & Wadhwa, R. (2021). COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: Insights from computational and biochemical assays. Journal of Biomolecular Structure and Dynamics, 2, 1–14. https://doi.org/10.1080/07391102.2021.1902858
   Google Scholar
• Kim, J. M., Chung, Y. S., Jo, H. J., Lee, N. J., Kim, M. S., Woo, S. H., Park, S., Kim, J. W., Kim, H. M., & Han, M. G. (2020). Identification of coronavirus isolated from a patient in Korea with covid-19. Osong Public Health and Research Perspectives, 11(1), 3–7. https://doi.org/10.24171/j.phrp.2020.11.1.02.
   PubMedGoogle Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–1213. https://doi.org/10.1093/nar/gkv951
   PubMed Web of Science ®Google Scholar
• Kim, Y., Jedrzejczak, R., Maltseva, N. I., Wilamowski, M., Endres, M., Godzik, A., Michalska, K., & Joachimiak, A. (2020). Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Science: A Publication of the Protein Society, 29(7), 1596–1605. https://doi.org/10.1002/pro.5560040401.
   PubMed Web of Science ®Google Scholar
• Kirtikar, K. R., & Basu, B. D. (1991). Indian Medicinal Plants, 2nd edn, Periodical experts book agency. Delhi. 1991; 2(2):1488.
   Google Scholar
• Kohnke, B., Kutzner, C., & Grubm€uller, H. (2020). A GPU-accelerated fast multipole method for GROMACS: Performance and accuracy. Journal of Chemical Theory and Computation, 16(11), 6938–6949. https://doi.org/10.1021/acs.jctc.0c00744
   PubMed Web of Science ®Google Scholar
• Kulkarni, S. K., & Dhir, A. (2008). Withania somnifera: An Indian ginseng. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(5), 1093–1105. https://doi.org/10.1021/acs.jctc.0c00744
   PubMed Web of Science ®Google Scholar
• Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020). Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics, 39, 1–13. https://doi.org/10.1080/07391102.2020.1772108
   Web of Science ®Google Scholar
• Lehmann, K. C., Gulyaeva, A., Zevenhoven-Dobbe, J. C., Janssen, G. M. C., Ruben, M., Overkleeft, H. S., van Veelen, P. A., Samborskiy, D. V., Kravchenko, A. A., Leontovich, A. M., Sidorov, I. A., Snijder, E. J., Posthuma, C. C., & Gorbalenya, A. E. (2015). Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses. Nucleic Acids Research, 43(17), 8416–8434. https://doi.org/10.1093/nar/gkv838.
   PubMed Web of Science ®Google Scholar
• Lengauer, T., & Rarey, M. (1996). Computational methods for biomolecular docking. Current Opinion in Structural Biology, 6(3), 402–406. https://doi.org/10.1016/S0959-440X(96)80061-3
   PubMed Web of Science ®Google Scholar
• Leung, J. M., Yang, C. X., & Sin, D. D. (2020). COVID-19 and nicotine as a mediator of ACE-2. European Respiratory Journal, 55(6), 2001261. https://doi.org/10.1183/13993003.01261-2020
   PubMed Web of Science ®Google Scholar
• Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237–261. https://doi.org/10.1146/annurev-virology-110615-042301
   PubMed Web of Science ®Google Scholar
• Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S. K., Huang, I. C., Xu, K., Vasilieva, N., Murakami, A., He, Y., Marasco, W. A., Guan, Y., Choe, H., & Farzan, M. (2005). Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. The EMBO Journal, 24(8), 1634–1643. https://doi.org/10.1146/annurev-virology-110615-042301.
   PubMed Web of Science ®Google Scholar
• Liu, X., & Wang, X. J. (2020). Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. Journal of Genetics and Genomics = Yi Chuan Xue Bao, 47(2), 119-e121. https://doi.org/10.1016/j.jgg.2020.02.001.
   Web of Science ®Google Scholar
• Liu, X., Zhang, B., Jin, Z., Yang, H., & Rao, Z. (2020). The crystal structure of 2019-nCoV main protease in complex with an inhibitor N3. Rcsb Pdb,. https://doi.org/10.2210/pdb6LU7/pdb
   Google Scholar
• Mandlik Ingawale, D. S., & Namdeo, A. G. (2020). Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. Journal of Dietary Supplements, 18, 1–44. https://doi.org/10.1080/19390211.2020.1741484
   Web of Science ®Google Scholar
• Mirjalili, M. H., Moyano, E., Bonfill, M., Cusido, R. M., & Palazón, J. (2009). Steroidal Lactones FROM Withania somnifera, an ancient plant for novel medicine. Molecules (Basel, Switzerland), 14(7), 2373–2393. https://doi.org/10.3390/molecules14072373.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, V. (2003). Trees and shrubs of Iran (pp. 874–877). Tehran, Iran: Farhange Moaser.
   Google Scholar
• Murza, A., Dion, S. P., Boudreault, P. L., Désilets, A., Leduc, R., & Marsault, É. (2020). Inhibitors of Type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature. Expert Opinion on Therapeutic Patents, 30(11), 807–824. https://doi.org/10.1080/13543776.2020.1817390.
   PubMed Web of Science ®Google Scholar
• Nascimento, I. J. B. d., Cacic, N., Abdulazeem, H. M., Groote, T. v., Jayarajah, U., Weerasekara, I., Esfahani, M. A., Civile, V. T., Marusic, A., Jeroncic, A., Junior, N. C., Pericic, T. P., Zakarija-Grkovic, I., Guimarães, S. M. M., Bragazzi, N. L., Bjorklund, M., Sofi-Mahmudi, A., Altujjar, M., Tian, M., Arcani, D. M. C., O Mathuna, D. P., Marcolino, M. S. (2020). Novel coronavirus. (2019-nCoV) infection in humans: a scoping review and meta-analysis. Journal of Clinical Medicine, 9(4), 941. https://doi.org/10.3390/jcm9040941
   PubMed Web of Science ®Google Scholar
• Paulsson-Habegger, L., Snabaitis, A. K., & Wren, S. P. (2021). Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection. Bioorganic & Medicinal Chemistry, 48, 116389. https://doi.org/10.1016/j.bmc.2021.116389.
   PubMed Web of Science ®Google Scholar
• Remya, C., Dileep, K. V., Variayr, E. J., & Sadasivan, C. (2016). An in silico guided identification of nAChR agonists from Withania somnifera. Frontiers in Life Science, 9(3), 201–213. https://doi.org/10.1080/21553769.2016.1207569
   Web of Science ®Google Scholar
• Saberinasab, A., Raissi, H., & Hashemzadeh, H. (2020). Predicting the efficiency of polyethylene glycol-functionalized graphene in delivery of temozolomide anticancer drug and investigating the effect of pH on the drug release process: DFT and free energy calculations. Molecular Simulation, 46(18), 1474–1482. https://doi.org/10.1080/08927022.2020.1845910
   Web of Science ®Google Scholar
• Saberinasab, A., Raissi, H., & Hashemzadeh, H. (2021). Molecular insight into the role of polyethylene glycol and cholesterol on the performance of graphene-based nanomaterials in Blood-brain barrier delivery. Journal of Molecular Liquids, 341, 117446. https://doi.org/10.1016/j.molliq.2021.117446
   Web of Science ®Google Scholar
• Sapra, L., Bhardwaj, A., Azam, Z., Madhry, D., Verma, B., Rathore, S., & Srivastava, R. K. (2021). Phytotherapy for treatment of cytokine storm in COVID-19. Fronts in Bioscience-Landmark, 26, 51–57.
   PubMed Web of Science ®Google Scholar
• Schrodinger (2017). Release, Schr€odinger. 4: Prime. Schrodinger, LLC. https://doi.org/10.52586/4924
   Google Scholar
• Sevajol, M., Subissi, L., Decroly, E., Canard, B., & Imbert, I. (2014). Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Research, 194, 90–99. https://doi.org/10.1016/j.virusres.2014.10.008.
   PubMed Web of Science ®Google Scholar
• Spinello, A., Saltalamacchia, A., & Magistrato, A. (2020). Is the rigidity of SARS-CoV2 spike receptor-binding motif the hallmark for its enhanced infectivity? Insights from all-atom simulations. The Journal of Physical Chemistry Letters, 11(12), 4785–4790. https://doi.org/10.1021/acs.jpclett.0c01148.
   PubMed Web of Science ®Google Scholar
• Straughn, A. R., & Kakar, S. S. (2020). Withaferin A: A potential therapeutic agent against COVID-19 infection. Journal of Ovarian Research, 13(1), 79. https://doi.org/10.1186/s13048-020-00684-x
   PubMed Web of Science ®Google Scholar
• Subissi, L., Posthuma, C. C., Collet, A., Zevenhoven-Dobbe, J. C., Gorbalenya, A. E., Decroly, E., Snijder, E. J., Canard, B., & Imbert, I. (2014). One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proceedings of the National Academy of Sciences of the United States of America, 111, 3900–3909. https://doi.org/10.1073/pnas.1323705111
   Web of Science ®Google Scholar
• Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & Molecular Immunology, 17(6), 613–620. https://doi.org/10.1038/s41423-020-0400-4
   PubMed Web of Science ®Google Scholar
• Tandon, N., & Yadav, S. S. (2020). Safety and clinical effectiveness of Withania Somnifera (Linn.) dunal root in human ailments. Journal of Ethnopharmacology, 255, 112768. https://doi.org/10.1016/j.jep.2020.112768.
   PubMed Web of Science ®Google Scholar
• Tiwari, R., Chakrabort, S., Saminathan, M., Dhama, K., & Singh, S. V. (2014). Ashwagandha (Withania somnifera): Role in safeguarding health, immunomodulatory effects, combating infections and therapeutic applications: a review. Journal of Biological Sciences, 14(2), 77–94. https://doi.org/10.3923/jbs.2014.77.94
   Google Scholar
• Tong, X., Zhang, H., & Timmerman, B. N. (2011). Chlorinated withanolides from Withania somnifera. Phytochemistry Letters, 4(4), 411–414. https://doi.org/10.1016/j.phytol.2011.04.016.
   PubMed Web of Science ®Google Scholar
• Tripathi, M. K., Singh, P., Sharma, S., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2021). Ethayathulla AS, Kaur P Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure & Dynamics, 39(15), 5668–5681. https://doi.org/10.1080/07391102.2020.1790425.
   PubMed Web of Science ®Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, Z., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Wu, K., Li, W., Peng, G., & Li, F. (2009). Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proceedings of the National Academy of Sciences of the United States of America, 106(47), 19970–19974. https://doi.org/10.1073/pnas.0908837106.
   PubMed Web of Science ®Google Scholar
• Yuan, L., Chen, Z., Song, S., Wang, S., Tian, C., Xing, G., Chen, X., Xiao, Z. X., He, F., & Zhang, L. (2015). P53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling. The Journal of Biological Chemistry, 290(5), 3172–3182. https://doi.org/10.1074/jbc.M114.619890.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Li, L., Yan, L., Ming, Z., Jia, Z., Lou, Z., & Rao, Z. (2018). Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East respiratory syndrome coronavirus. Journal of Virology, 92(22), e0089. https://doi.org/10.1128/JVI.00893-18
   Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405.
   PubMed Web of Science ®Google Scholar
• Ziebuhr, J. (2005). The coronavirus replicase. Current Topics in Microbiology and Immunology, 287, 57–94. https://doi.org/10.1007/3-540-26765-4_3.
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K. Y. (2016). Coronaviruses – Drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37.
   PubMed Web of Science ®Google Scholar